Specialist Updates 
Oncology

New combo therapy ‘effective first line in advanced renal cancer’

The first results of the CheckMate 9ER trial show a good response rate and improved survival, researchers say
Medicom Staff writer
0
23 September 2020
Save
ClosePlease login

AusDoc brings you the latest news from the European Society for Medical Oncology virtual congress 2020.

A checkpoint inhibitor partnered with a targeted chemotherapy agent could be a new first-line option for patients with advanced renal cell carcinoma, a leading oncologist says.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .